Similar Articles
691
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
692
Multidisciplinary approach for multifocal, bilobar hepatocellular carcinoma: A case report and literature review
693
Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation
694
Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
695
Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma
696
Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma
697
Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
698
One in five hepatocellular carcinoma patients in the United States are Hispanic while less than 40% were eligible for liver transplantation
699
Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
700
Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future
Page 70 of 175 ( 1742 items )
<<
1
...
66
67
68
69
70
71
72
73
...
175
>>
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA